Alterations in Molecular Pathways in the Retina of Early Experimental Glaucoma Eyes
Overview
Authors
Affiliations
Glaucoma is a multifactorial, neurodegenerative disease. The molecular mechanisms that underlie the pathophysiological changes in glaucomatous eyes, especially at the early stage of the disease, are poorly understood. Here, we report the findings from a quantitative proteomic analysis of retinas from experimental glaucoma (EG) eyes. An early stage of EG was modeled on unilateral eyes of five nonhuman primates (NHP) by laser treatment-induced elevation of intraocular pressure (IOP). Retinal proteins were extracted from individual EG eyes and their contralateral control eyes of the same animals, respectively, and analyzed by quantitative mass spectrometry (MS). As a result, a total, 475 retinal proteins were confidently identified and quantified. Results of bioinformatic analysis of proteins that showed an increase in the EG eyes suggested changes in apoptosis, DNA damage, immune response, cytoskeleton rearrangement and cell adhesion processes. Interestingly, hemoglobin subunit alpha (HBA) and Ras related C3 botulinum toxin substrate 1 (Rac1) were among the increased proteins. Results of molecular modeling of HBA- and Rac1-associated signaling network implicated the involvement of Mitogen-Activated Protein Kinase (MAPK) pathway in the EG, through which Rac1 may exert a regulatory role on HBA. This is the first observation of this potentially novel signaling network in the NHP retina and in EG. Results of Western blot analyses for Rac1, HBA and a selected MAPK pathway protein indicated synergistic changes in all three proteins in the EG eyes. Further, results of hierarchical cluster analysis of proteomes of control eyes revealed a clear age-proteome relationship, and such relationship appeared disrupted in the EG eyes. In conclusion, our results suggested an increased presence of a potentially novel signaling network at the early stage of glaucoma, and age might be one of the determinant factors in retinal proteomic characteristics under normal conditions.
Zhou L, Lin D, Xu G, Wang X, Chen Z, Wang D Front Neurol. 2023; 14:1091697.
PMID: 37034083 PMC: 10073422. DOI: 10.3389/fneur.2023.1091697.
Minocycline reduces inflammatory response and cell death in a S100B retina degeneration model.
Grotegut P, Perumal N, Kuehn S, Smit A, Dick H, Grus F J Neuroinflammation. 2020; 17(1):375.
PMID: 33317557 PMC: 7737388. DOI: 10.1186/s12974-020-02012-y.
Zhang M, Zhao G, Hou Y, Zhong S, Xu L, Li F Cell Death Dis. 2020; 11(9):734.
PMID: 32913260 PMC: 7484783. DOI: 10.1038/s41419-020-02951-7.
Distinct plasma proteomic changes in male and female African American stroke patients.
Cao L, Cobbs A, Simon R, Zhou A Int J Physiol Pathophysiol Pharmacol. 2019; 11(2):12-20.
PMID: 31149323 PMC: 6526384.
Bell K, Funke S, Grus F Ophthalmologe. 2018; 116(1):18-27.
PMID: 29427020 DOI: 10.1007/s00347-018-0658-4.